Laser or cream? new study tests best treatment for lichen sclerosus
NCT ID NCT05010421
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two treatments for lichen sclerosus, a chronic skin condition causing itching and pain. 246 women received either a non-ablative CO2 laser treatment or a steroid cream (clobetasol) for three months. The goal was to see which works better at reducing symptoms like burning and pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clobetasol 0.05% cream and non-ablative CO2 laser
- What this could lead to
- If successful, this could show that laser treatment is as good as or better than standard steroid cream for managing lichen sclerosus symptoms.
- What could go wrong
- This is a single completed trial, so results may not apply to all patients. Both treatments have side effects like skin irritation or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LICHEN SCLEROSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Marien Hospital Herne
Herne, North Rhine-Westphalia, 44625, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.